European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like NHSc’s HMO blend deemed effective for babies allergic to cow’s milk protein August 16, 2021 HMOs offer protection from tooth decay as formula ingredient July 9, 2020 A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024
A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024